Literature DB >> 24293007

B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Wasif N Khan1, Jacqueline A Wright, Eden Kleiman, Justin C Boucher, Iris Castro, Emily S Clark.   

Abstract

B-lymphocytes are integral to host defense against microbial pathogens and are associated with many autoimmune diseases. The B-cell receptor implements B-cell self-tolerance based on the antigen specificity, and B-cell-activating factor receptor (BAFF-R) imposes homeostatic control. While shaping the repertoire, the immune tolerance process also culls mature B cells into distinct populations. The activation response of B cells is tailored to the type of pathogen attack and is facilitated by T-cell help via CD40/CD40L interaction and/or innate cell help via toll-like receptors in conjunction with BAFF receptors and ligands. Activated effector B cells not only produce antibodies, but also produce a variety of cytokines to enhance and suppress the immune response. Not surprisingly, B cells play multiple roles in both humoral and cellular immune responses during infection and autoimmune pathogenesis. Here, we discuss how gene expression and signaling networks regulate peripheral B-cell tolerance, B-cell effector functions and emerging therapies targeting B-cell signaling in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24293007     DOI: 10.1007/s12026-013-8466-z

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  206 in total

Review 1.  Autoreactivity by design: innate B and T lymphocytes.

Authors:  A Bendelac; M Bonneville; J F Kearney
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

2.  Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.

Authors:  Caroline A Jefferies; Sarah Doyle; Cornelia Brunner; Aisling Dunne; Elizabeth Brint; Claudia Wietek; Eva Walch; Thomas Wirth; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

3.  B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2.

Authors:  Iris Castro; Jacqueline A Wright; Bazarragchaa Damdinsuren; Kristen L Hoek; Gianluca Carlesso; Nicholas P Shinners; Rachel M Gerstein; Robert T Woodland; Ranjan Sen; Wasif N Khan
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 4.  Initiation and processing of signals from the B cell antigen receptor.

Authors:  M Reth; J Wienands
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  The structure of the TNFRSF13C promoter enables differential expression of BAFF-R during B cell ontogeny and terminal differentiation.

Authors:  Stephen A Mihalcik; Paul M Huddleston; Xiaosheng Wu; Diane F Jelinek
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

6.  Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development.

Authors:  Thomas T Su; David J Rawlings
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

Review 7.  Bruton's Tyrosine Kinase is involved in innate and adaptive immunity.

Authors:  C Brunner; B Müller; T Wirth
Journal:  Histol Histopathol       Date:  2005-07       Impact factor: 2.303

Review 8.  Human B cell tolerance and its failure in rheumatoid arthritis.

Authors:  Jonathan Samuels; Yen-Shing Ng; Claire Coupillaud; Daniel Paget; Eric Meffre
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

9.  Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim.

Authors:  Gayle M Davey; Christian Kurts; Jacques F A P Miller; Philippe Bouillet; Andreas Strasser; Andrew G Brooks; Francis R Carbone; William R Heath
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

Review 10.  IFNα Inducible Models of Murine SLE.

Authors:  Zheng Liu; Anne Davidson
Journal:  Front Immunol       Date:  2013-10-02       Impact factor: 7.561

View more
  12 in total

1.  Dendritic cell targeted vaccines: Recent progresses and challenges.

Authors:  Pengfei Chen; Xinsheng Liu; Yuefeng Sun; Peng Zhou; Yonglu Wang; Yongguang Zhang
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D Progression.

Authors:  Tania Habib; S Alice Long; Peter L Samuels; Archana Brahmandam; Megan Tatum; Andrew Funk; Anne M Hocking; Karen Cerosaletti; Michael T Mason; Elizabeth Whalen; David J Rawlings; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2019-03-20       Impact factor: 9.461

3.  Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis.

Authors:  Brittany L Hartwell; Chad J Pickens; Martin Leon; Cory Berkland
Journal:  Biomacromolecules       Date:  2017-05-17       Impact factor: 6.988

4.  The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs).

Authors:  Zahava Vadasz; Tova Rainis; Afif Nakhleh; Tharwat Haj; Jacob Bejar; Katty Halasz; Elias Toubi
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

5.  Transgenic overexpression of BAFF regulates the expression of immune-related genes in zebrafish, Danio rerio.

Authors:  Li Zhang; Chao Liu; Xin Zhou; Ying Xie; Libo Su; Qi Geng; Binghui Liu; Shufeng Liu
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

6.  B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade.

Authors:  Shubhra Singh; Jason Roszik; Neeraj Saini; Vipul Kumar Singh; Karishma Bavisi; Zhiqiang Wang; Long T Vien; Zixi Yang; Suprateek Kundu; Richard E Davis; Laura Bover; Adi Diab; Sattva S Neelapu; Willem W Overwijk; Kunal Rai; Manisha Singh
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

7.  Inhibition of the IRE-1α/XBP-1 pathway prevents chronic GVHD and preserves the GVL effect in mice.

Authors:  Steven D Schutt; Yongxia Wu; Chih-Hang Anthony Tang; David Bastian; Hung Nguyen; M Hanief Sofi; MengMeng Zhang; Chen Liu; Kris Helke; Carole Wilson; Lynn M Schnapp; Juan R Del Valle; Chih-Chi Andrew Hu; Xue-Zhong Yu
Journal:  Blood Adv       Date:  2018-02-27

8.  Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice.

Authors:  Kevin M Nickerson; Yujuan Wang; Sheldon Bastacky; Mark J Shlomchik
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

9.  Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study.

Authors:  Linda L Kusner; Michael J Ciesielski; Alexander Marx; Henry J Kaminski; Robert A Fenstermaker
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

10.  Lower BAFF Levels in Myasthenic Patients Treated with Glucocorticoids.

Authors:  Ewa Sobieszczuk; Piotr Szczudlik; Justyna Kubiszewska; Beata Szyluk; Marta Lipowska; Małgorzata Dutkiewicz; Anna Kostera-Pruszczyk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-08-02       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.